According to Luoxin Pharmaceutical's announcement, the total shareholders of the company, Deyi Xinhua, Deyi Chengdu, Deyi Health, and Desheng Health, hold a total of 58.7045 million shares of the company, accounting for 5.40% of the company's total share capital. Due to the share transfer dispute, the Beijing Chaoyang District People's Court intends to implement judicial execution on some of the company's shares held by the above shareholders. The total number of shares to be executed is 2011.87 million shares, accounting for 1.85% of the company's total share capital. The execution method is centralized bidding or bulk transactions. The execution period is within 90 days from the date the ruling comes into effect, and the actual number of executions is based on the court's final results. This disposition is a passive judicial execution, will not lead to a change in the company's control, and will not have a significant impact on the company's daily operations.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.